WACKER ist Technologieführer der chemischen Industrie und produziert für alle globalen Schlüsselindustrien und ist in den Bereichen Silicone, Polymere, Life Sciences und Polysilicium tätig.
German chemical company Wacker Chemie has broken ground for its new production site in Karlovy Vary, Czech Republic. Wacker plans to produce room-temperature-curing high-performance silicones there from the end of 2025 and high-consistency silicone rubbers from 2028.
In a move to expand its expertise and business in silicone-coated healthcare products, Germany’s Wacker Chemie has acquired the manufacturing assets and know-how of US-based Bio Med Sciences. As part of the acquisition, a majority of Bio Med Sciences’ workforce will also move to Wacker, the company said. Financial details of the transaction were not disclosed.
Wacker Chemie started the construction of several new production lines to expand its specialty silicone manufacturing capacities at the Zhangjiagang site in Jiangsu Province, China. At the site, which is one of Wacker’s largest fully integrated production sites, the globally operating chemical group will produce functional silicone fluids, silicone emulsions and silicone elastomer gels. Investments of some €150 million are planned for the expansion project, Wacker said.
Following up on expansion plans hinted at last year, Germany’s Wacker Chemie is proposing to build up its US complex at Charleston, Tennessee, into a center for silicone specialties.
With an eye to expanding production capacity for silicon metal, Germany’s Wacker Chemie has launched a feasibility study to carry out a capacity upgrade at its site in Holla, Norway.
